GoalVest Advisory’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50	Closed	-$71	–	361
2025 Q1	$71	Buy	+50	New	+$71	﹤0.01%	502